Therefore, the present results support previous observations (with Western blotting, ELISA and immunocytochemistry techniques) that constitutional properties of the EOM compensate for the lack of dystrophin, allowing a better response against myonecrosis [11], [43]. The gene discussed is DMD; the disease is gas gangrene.